Precision Optics (POCI) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
29 Sep, 2026Fiscal 2026 performance and financial highlights
Achieved record revenue of $31.5 million in FY2026, representing 65% growth over FY2025 and exceeding guidance.
Delivered two consecutive quarters of positive Adjusted EBITDA, with Q4 FY26 at $0.4 million.
Gross margin improved to 25.3% in Q4 FY26, up from 13.0% a year earlier.
Ended FY2026 with $9.8 million in cash and a net cash position of $8.6 million.
Strengthened balance sheet through an $11.5 million public offering in March 2026.
Business model, operations, and technology
Vertically integrated model enables rapid concept-to-production cycles and high-yield manufacturing.
Proprietary micro-optics, multi-channel, and digital imaging platforms serve space, defense/aerospace, and medical device markets.
Unity Imaging Platform offers modular, customizable endoscopic systems, reducing development time and cost.
Four operating units and in-house resources support design, engineering, and production under one roof.
Ross Optical division provides global sourcing and inspection of optical components.
Key markets and growth drivers
Space: Sole-source supplier for a major LEO satellite optical assembly, with a second satellite customer added in September 2026.
Defense/Aerospace: Long-term programs with major contractors and new agreements for high-end inspection devices.
Medical Device: Volume production of single-use cystoscopes for surgical robotics, with strong recurring demand.
Market diversification supported by a robust product development pipeline across all segments.
Satellite laser communication and disposable endoscope markets forecasted to grow at double-digit CAGRs.
Latest events from Precision Optics
- Revenue and margins surged as new satellite and medical device programs fueled rapid growth.POCI
Lytham Partners Fall 2026 Investor Conference - Record revenue and margin gains, but FY 2027 outlook impacted by satellite order slowdown.POCI
Q4 2026 - Growth accelerates as micro-optics drive expansion in satellite, defense, and single-use endoscopy.POCI
Lytham Partners 2026 Consumer & Technology Investor Summit - Production ramp in medical and satellite optics drives revenue growth and margin recovery.POCI
Planet MicroCap Las Vegas 2026 - Accelerated revenue growth driven by new production programs and robust technology pipeline.POCI
Lytham Partners Spring 2026 Investor Conference - Strong revenue growth, major new orders, and expanding product pipeline drive future prospects.POCI
Corporate presentation - Record Q3 revenue, margin gains, and a $10M+ offering drove raised FY2026 guidance.POCI
Q3 2026 - Strong revenue growth and major orders fuel expansion in medical and defense optics.POCI
Investor presentation - Revenue and margins fell, but backlog and new contracts support a strong Q4 outlook.POCI
Q3 2025